Sam Slutsky

Stock Analyst at LifeSci Capital

(2.97)
# 1,533
Out of 5,084 analysts
3
Total ratings
66.67%
Success rate
60.48%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Sam Slutsky

Palvella Therapeutics
Aug 4, 2025
Initiates: Outperform
Price Target: $90
Current: $93.90
Upside: -4.15%
ABIVAX Société Anonyme
Jul 23, 2025
Maintains: Outperform
Price Target: $45$101
Current: $109.64
Upside: -7.88%
InflaRx
Apr 5, 2023
Upgrades: Outperform
Price Target: n/a
Current: $1.11
Upside: -